Valion Bio, Inc. Basic Shares Outstanding (Weighted Average)
Valion Bio, Inc. (VBIO) reported Basic Shares Outstanding (Weighted Average) of 3.38 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-14
- Valion Bio, Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 3.38M shares, a 283.53% increase year-over-year.
- Valion Bio, Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 2.88M shares, a 406.47% increase year-over-year.
- Valion Bio, Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 1.84M shares, a 297.57% increase year-over-year.
- Valion Bio, Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 1.32M shares, a 262.67% increase year-over-year.
- Valion Bio, Inc. weighted average number of shares outstanding, basic for fiscal 2025 was 1.16M shares, a 302.11% increase from fiscal 2024.
- Valion Bio, Inc. weighted average number of shares outstanding, basic for fiscal 2024 was 287.37K shares, a 516.01% increase from fiscal 2023.
- Valion Bio, Inc. weighted average number of shares outstanding, basic for fiscal 2023 was 46.65K shares, a 51.80% decline from fiscal 2022.
- Valion Bio, Inc. weighted average number of shares outstanding, basic for fiscal 2022 was 96.78K shares, a 97.23% decline from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Basic 1 month | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 3 month as first filed | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 6 month as first filed | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 9 month as first filed | Weighted Average Number of Shares Outstanding, Basic 12 month | Weighted Average Number of Shares Outstanding, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 3.38M shares 10-Q · filed 2026-08-14 | 3.00M shares 10-Q · filed 2026-08-14 | 2.70M shares derived: average of 3 quarters · filed 2026-08-14 | 2.35M shares derived: average of 4 quarters · filed 2026-08-14 | |||||
| 2026-03-31 | 2.88M shares 10-Q · filed 2026-05-14 | 2.36M shares derived: average of 2 quarters · filed 2026-05-14 | 2.01M shares derived: average of 3 quarters · filed 2026-05-14 | 1.73M shares derived: average of 4 quarters · filed 2026-08-14 | |||||
| 2025-12-31 | 1.84M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | 1.58M shares derived: average of 2 quarters · filed 2026-03-30 | 1.35M shares derived: average of 3 quarters · filed 2026-08-14 | 1.16M shares 10-K · filed 2026-03-30 | |||||
| 2025-09-30 | 1.32M shares 10-Q · filed 2025-11-14 | 1.10M shares derived: average of 2 quarters · filed 2026-08-14 | 928.97K shares 10-Q · filed 2025-11-14 | 808.26K shares derived: average of 4 quarters · filed 2026-08-14 | |||||
| 2025-06-30 | 881.29K shares 10-Q · filed 2026-08-14 | 739.62K shares 10-Q · filed 2026-08-14 | 637.42K shares derived: average of 3 quarters · filed 2026-08-14 | 569.11K shares derived: average of 4 quarters · filed 2026-08-14 | |||||
| 2025-03-31 | 569.37K shares 10-Q · filed 2026-05-14 | 596.37K shares 10-Q · filed 2025-05-15 | 515.49K shares derived: average of 2 quarters · filed 2026-05-14 | 465.05K shares derived: average of 3 quarters · filed 2026-05-14 | 407.76K shares derived: average of 4 quarters · filed 2026-05-14 | ||||
| 2024-12-31 | 461.61K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | 412.90K shares derived: average of 2 quarters · filed 2026-03-30 | 353.89K shares derived: average of 3 quarters · filed 2026-03-30 | 287.37K shares 10-K · filed 2026-03-30 | |||||
| 2024-09-30 | 364.18K shares 10-Q · filed 2025-11-14 | 6.19M shares 10-Q · filed 2024-11-14 | 300.03K shares derived: average of 2 quarters · filed 2025-11-14 | 229.29K shares 10-Q · filed 2025-11-14 | 3.90M shares 10-Q · filed 2024-11-14 | -206.42K shares derived: average of 4 quarters · filed 2025-11-14 | |||
| 2024-06-30 | 235.87K shares 10-Q · filed 2025-08-14 | 4.01M shares 10-Q · filed 2024-08-14 | 161.10K shares 10-Q · filed 2025-08-14 | 2.74M shares 10-Q · filed 2024-08-14 | -396.63K shares derived: average of 3 quarters · filed 2025-08-14 | -14.25 shares derived: average of 4 quarters · filed 2025-08-14 | |||
| 2024-03-31 | 86.34K shares 10-Q · filed 2025-05-15 | 1.47M shares 10-Q · filed 2024-05-15 | -712.87K shares derived: average of 2 quarters · filed 2025-05-15 | -78.64K shares derived: average of 3 quarters · filed 2025-05-15 | 15.21K shares derived: average of 4 quarters · filed 2025-05-15 | ||||
| 2023-12-31 | -1.51M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-21 | -161.13K shares derived: average of 2 quarters · filed 2025-03-21 | -8.49K shares derived: average of 3 quarters · filed 2025-03-21 | 46.65K shares 10-K · filed 2025-03-21 | 793.04K shares 10-K · filed 2024-03-25 | ||||
| 2023-09-30 | 1.19M shares 10-Q · filed 2024-11-14 | 743.30K shares derived: average of 2 quarters · filed 2024-11-14 | 566.23K shares 10-Q · filed 2024-11-14 | 446.20K shares derived: average of 4 quarters · filed 2024-11-14 | |||||
| 2023-06-30 | 296.78K shares 10-Q · filed 2024-08-14 | 29.68M shares 10-Q · filed 2023-08-14 | 249.26K shares 10-Q · filed 2024-08-14 | 24.93M shares 10-Q · filed 2023-08-14 | 198.32K shares derived: average of 3 quarters · filed 2024-08-14 | 172.94K shares derived: average of 4 quarters · filed 2024-08-14 | |||
| 2023-03-31 | 201.22K shares 10-Q · filed 2024-05-15 | 20.12M shares 10-Q · filed 2023-05-15 | 149.10K shares derived: average of 2 quarters · filed 2024-05-15 | 131.66K shares derived: average of 3 quarters · filed 2024-05-15 | 2.50M shares derived: average of 4 quarters · filed 2024-05-15 | ||||
| 2022-12-31 | 96.97K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-25 | 96.88K shares derived: average of 2 quarters · filed 2024-03-25 | 3.27M shares derived: average of 3 quarters · filed 2024-03-25 | 96.78K shares 10-K · filed 2024-03-25 | 9.67M shares 10-K · filed 2023-03-31 | ||||
| 2022-09-30 | 96.78K shares 10-Q · filed 2023-11-14 | 9.68M shares 10-Q · filed 2022-11-14 | 4.86M shares derived: average of 2 quarters · filed 2023-11-14 | 96.71K shares 10-Q · filed 2023-11-14 | 9.67M shares 10-Q · filed 2022-11-14 | 6.53M shares derived: average of 4 quarters · filed 2023-11-14 | |||
| 2022-06-30 | 9.62M shares 10-Q · filed 2023-08-14 | 9.67M shares 10-Q · filed 2023-08-14 | 8.67M shares derived: average of 3 quarters · filed 2023-08-14 | 7.15M shares derived: average of 4 quarters · filed 2023-08-14 | |||||
| 2022-03-31 | 9.72M shares 10-Q · filed 2023-05-15 | 8.20M shares derived: average of 2 quarters · filed 2023-05-15 | 6.33M shares derived: average of 3 quarters · filed 2023-05-15 | 5.34M shares derived: average of 4 quarters · filed 2023-05-15 | |||||
| 2022-01-31 | 9.72M shares 10-Q · filed 2022-05-16 | ||||||||
| 2021-12-31 | 6.68M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | 4.63M shares derived: average of 2 quarters · filed 2023-03-31 | 3.88M shares derived: average of 3 quarters · filed 2023-03-31 | 3.49M shares 10-K · filed 2023-03-31 | |||||
| 2021-09-30 | 2.58M shares 10-Q · filed 2022-11-14 | 2.48M shares derived: average of 2 quarters · filed 2022-11-14 | 2.43M shares 10-Q · filed 2022-11-14 | ||||||
| 2021-06-30 | 2.37M shares 10-Q · filed 2022-08-15 | 2.35M shares 10-Q · filed 2022-08-15 | |||||||
| 2021-03-31 | 2.33M shares 10-Q · filed 2022-05-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |